期刊文献+

中国类风湿关节炎患者报告的临床结局量表优化研究 被引量:4

Study on Optimization of Chinese RA Patient-reported Outcome Scale
原文传递
导出
摘要 目的:优化并修订"基于中国人报告的类风湿关节炎患者临床结局(PRO)量表"。方法:采用描述性研究,通过开展全国范围内多中心横断面调查进行原PRO量表应用评估,运用描述性分析、克朗巴赫系数法、因子分析法、多重线性回归等统计学方法进行条目优化、权重分配、评分方法、活动分级等优化量表。结果:共纳入来自全国19个省市23家医疗机构的1868例患者进行量表应用评估,通过数据分析将原条目进行删减、合并,拟合PRO总分与各条目的线性回归模型,得到修订后PRO总分的计算公式,并进行初步的活动度分为4个等级。优化后的PRO量表总体Cronbachα值为0.756,折半信度为0.733,共提取3个公因子,累计贡献率达53.199%。结论:优化后的中国类风湿关节炎患者报告的临床结局量表较原量表更加简洁、实用性及操作性更强,有待于进一临床推广应用和完善。 Objective: To optimize and revise the"Chinese RA patient-reported outcome scale". Method: A nationwide cross-sectional study was carried out to evaluate the scale by descriptive research method. Several statistical methods such as descriptive analysis,Cronbachα,factor analysis and multiple linear regression were adopted to optimize the items,assign weights,calculate the score and classify the activity. Result: A total of 1868 patients from 23 hospitals of 19 cities were investigated to evaluate the scale. The original items were cut and combined and the linear regression model was fitted to get the weight assignment. And then the final computational formula and the activity classification was obtained. The Cronbach α of the revised scale was 0. 756 and the split-half reliability coefficient was 0. 733. Three main common factors were extracted and the accumulating contribution rate was 53. 199%. Conclusion: The optimized scale was more concise and practical with more operability. But it remains to be perfected and needs more popularized application in clinics.
作者 韩曼 巩勋 唐晓颇 刘宏潇 刘健 何东仪 张俊莉 李振彬 黄清春 王新昌 吴庆军 方勇飞 汪悦 陈适 蒋红 高明利 刘维 刘英 李泽光 赵钟文 王成武 刘维超 王海东 娄玉钤 孟庆良 阮崇杰 谢雁鸣 姜泉 HAN Man;GONG Xun;TANG Xiaopo;LIU Hongxiao;LIU Jian;HE Dongyi;ZHANG Junli;LI Zhenbin;HUANG Qingchun;WANG Xinchang;WU Qingjun;FANG Yongfei;WANG Yue;CHEN Shi;JIANG Hong;GAO Mingli;LIU Wei;LIU Ying;LI Zeguang;ZHAO Zhongwen;WANG Chengwu;LIU Weichao;WANG Haidong;LOU Yuqian;MENG Qingliang;RUAN Chongjie;XIE Yanming;JIANG Quan(Rheumatology Department,Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China;The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine,Hefei 230031,Anhui,China;Institute of Arthritis Research,Shanghai Academy of Chinese Medical Sciences,Guanghua Integrative Medicine Hospital,Shanghai 200052,China;Rheumatology Department,The Fifth Hospital of Xi'an City,Xi'an 710082,Shaanxi,China;Rheumatology Department,Bethune international peace hospital,Shijiazhuang 050082,Hebei,China;Rheumatology Department,Guangzhou Provincial Hospital of Traditional Chinese Medicine,Guangzhou 518021,Guangdong,China;Rheumatology Department,The Second Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou 310004,China;Rheumatology Department,Peking Union Medical College Hospital,Beijing 100032,China;Rheumatology Department,Southwest Hospital,Third Military Medical University,Chongqing 400038,China;Jiangsu Provincial Hospital of Traditional Chinese Medicine,Nanjing 210029,Jiangsu,China;Rheumatology Department,Peking University People's Hospital,Beijing 100044,China;Rheumatology Department,The Ninth People's Hospital of Chongqing City,Chongqing 400700,China;Rheumatology Department,The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110032,Liaoning,China;Rheumatology Department,The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300192,China;Rheumatology Department,The Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250011,Shandong,China;Rheumatology Department,The First Affiliated Hospital of Heihingjiang University of Traditional Chinese Medicine,Harbin 150040,Heilongjiang,China;Rheumatology Department,The Second People's Hospital of Fujian Province,Fuzhou 350003,Fujian,China;Rheumatology Department,The First Affiliated Hospital of Chaogchtm University of Traditional Chinese Medicine,Changchun 130021,Jilin,China 19.Rheumatology Department,Yunnan Provincial Hospital of Traditional Chinese Medicine,Kunming 650021,Yunnan,China;0.Rheurnatology Department,Gansu Provincial Hospital of Traditional Chinese Medicine,Lanzhou 730050,Gansu,Chin;1.Henan Rheumatism Hospital,Zhengzhou 450045,Henan,Chin;2.Rheumatology Department,Henan Provincial Hospital of Traditional Chinese Medicine,Zhengzhou 450000,Henan,Chin;3.Rheumatology and Pain Management Department,Wnhan Hospital of Traditional Chinese Medicine,Wuhan 430014,Hubei,Chin;4.Clinical Evaluation Center,China Academy of Chinese Medical Sciences,Beijing 100053,China)
出处 《中华中医药学刊》 CAS 北大核心 2018年第9期2116-2120,共5页 Chinese Archives of Traditional Chinese Medicine
基金 国家“十二五”科技支撑计划项目(2013BAI02B06)
关键词 类风湿关节炎 患者报告的临床结局 量表优化 rheumatoid arthritis patient- reported outcome scale optimization
  • 相关文献

参考文献8

二级参考文献37

  • 1郭庆科,周晶.Likert量表分析中不同IRT模型的有效性[J].心理学探新,2004,24(3):67-70. 被引量:36
  • 2郭义霞,刘朝杰,李宁秀,任晓晖.生命质量评价领域及其权重值的确定方法[J].现代预防医学,2004,31(1):4-6. 被引量:15
  • 3王天芳,王庆国,薛晓琳,赵燕,于春光,李志更,焦扬.中医症状规范化研究的现状与思路[J].北京中医药大学学报,2005,28(4):19-22. 被引量:28
  • 4杨宇.多指标综合评价中赋权方法评析[J].统计与决策,2006,22(13):17-19. 被引量:218
  • 5龚燕冰,倪青,王永炎.中医证候研究的现代方法学述评(二)——中医证候的量化及数理统计方法[J].北京中医药大学学报,2007,30(1):5-8. 被引量:47
  • 6Pincus T, Bergman MJ, Yazici Y, et al. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures[J]. Rheumatology, 2008,47 (3) : 345 - 349.
  • 7PincusT, Segurado OG. Most visits of mostpatients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count[J]. Ann Rheum Dis, 2006, 65(6) :820- 822.
  • 8Pincus T, Amara I, Segurado OG, et al. Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials[J]. J Rheumatol, 2008, 35(2) :201 - 205.
  • 9U. S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, FDA Center for Biologics Evaluation and Research, FDA Center for Devices and Radiological Health. Guidance for inductory; Patient-reported outcome measures: use in medical product development to support labeling claims:draft guidance[J]. Health Qual Life Outcome, 2006, (4) : 79.
  • 10Kirwan J, Heiberg T, Hewlett S,et al. Outcomes from the Patient Perspective Workshop at OMERACT 6 [ J ]. J Rheumatol, 2003,30 (4) : 868 - 872.

共引文献1035

同被引文献39

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部